Literature DB >> 3034423

Phase II trial of etoposide in the management of advanced or recurrent mixed mesodermal sarcomas of the uterus: a Gynecologic Oncology Group Study.

R E Slayton, J A Blessing, P J DiSaia, W A Christopherson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3034423

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  5 in total

1.  Major clinical research advances in gynecologic cancer in 2010.

Authors:  Dong Hoon Suh; Jae Weon Kim; Kidong Kim; Soon-Beom Kang
Journal:  J Gynecol Oncol       Date:  2010-12-31       Impact factor: 4.401

Review 2.  Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors:  J M Henwood; R N Brogden
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

3.  Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study.

Authors:  Matthew A Powell; Virginia L Filiaci; Peter G Rose; Robert S Mannel; Parviz Hanjani; Koen Degeest; Brigitte E Miller; Nobuyuki Susumu; Frederick R Ueland
Journal:  J Clin Oncol       Date:  2010-04-26       Impact factor: 44.544

4.  A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage I-IV uterine carcinosarcoma.

Authors:  Vicky Makker; Nadeem R Abu-Rustum; Kaled M Alektiar; Carol A Aghajanian; Qin Zhou; Alexia Iasonos; Martee L Hensley
Journal:  Gynecol Oncol       Date:  2008-08-27       Impact factor: 5.482

5.  Paclitaxel and Carboplatin for Uterine Carcinosarcoma: A Path to Inclusion.

Authors:  Dario R Roque; Daniela Matei
Journal:  J Clin Oncol       Date:  2022-01-19       Impact factor: 44.544

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.